HealthSouth Corp. Hits New 52-Week High at $36.85 (HLS)
HealthSouth Corp. (NYSE:HLS)’s share price reached a new 52-week high during trading hours on Monday, Analyst Ratings.Net reports. The company traded as high as $36.85 and last traded at $36.54, with a volume of 398,623 shares traded. The stock had previously closed at $36.33.
Several analysts have recently commented on the stock. Analysts at TheStreet upgraded shares of HealthSouth Corp. from a “hold” rating to a “buy” rating in a research note to investors on Monday, October 14th. Finally, analysts at Zacks upgraded shares of HealthSouth Corp. from a “neutral” rating to an “outperform” rating in a research note to investors on Thursday, September 26th. They now have a $37.30 price target on the stock. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $33.29.
HealthSouth Corp. has a 52 week low of $19.85 and a 52 week high of $36.85. The stock has a 50-day moving average of $34.47 and a 200-day moving average of $31.01. The company has a market cap of $3.184 billion and a price-to-earnings ratio of 12.03.
HealthSouth Corp. (NYSE:HLS) last announced its earnings results on Thursday, July 25th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.09. The company had revenue of $564.50 million for the quarter, compared to the consensus estimate of $553.63 million. During the same quarter in the previous year, the company posted $0.39 earnings per share. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. Analysts expect that HealthSouth Corp. will post $1.82 EPS for the current fiscal year.
HealthSouth Corporation (NYSE:HLS) is an owner and operator of inpatient rehabilitation hospitals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.